P. Nishanian

发表

HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.

J. Margolick, J. Phair, C. Kleeberger, 1996, Journal of immunology.

Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results.

J. Fahey, P. Nishanian, R. Mitsuyasu, 1986, The American journal of medicine.

Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation

R. Schooley, J. Fahey, J. Reuben, 2000, Clinical Diagnostic Laboratory Immunology.

Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset.

R. Detels, J. Taylor, J. Fahey, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Different lymphoid cell populations produce varied levels of neopterin, β2‐microglobulin and soluble IL‐2 receptor when stimulated with IL‐2, interferon‐gamma or tumour necrosis factor‐alpha

R. Figlin, J. Fahey, B. Hofmann, 1992, Clinical and experimental immunology.

HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism.

A. Nel, J. Fahey, R. L. Baldwin, 1990, Journal of immunology.

Leukemia derived growth factors produced by human malignant T-lymphoid cell lines.

J. Fahey, C. Uittenbogaart, P. Nishanian, 1986, Cancer research.

Predictors for Failure of Pneumocystis carinii Pneumonia Prophylaxis

J. Margolick, J. Phair, D. Seminara, 1995 .

Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population

R. Detels, J. Fahey, A. Saah, 1987, Journal of clinical microbiology.

A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.

R. Detels, J. Fahey, P. Nishanian, 1990, The Journal of infectious diseases.

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

J. Berzofsky, M. Clerici, J. Giorgi, 1992, The Journal of infectious diseases.

Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease.

R. Detels, J. Fahey, Y. Wang, 1991, AIDS.

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

J M Taylor, J V Giorgi, R. Detels, 1990, The New England journal of medicine.

Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes

R. Detels, W. Cumberland, M. Kemeny, 1997, Clinical and diagnostic laboratory immunology.

Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.

W. Cumberland, J. Fahey, W. Hardy, 1992, Clinical immunology and immunopathology.

Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.

M. Lederman, R. Detels, J. Taylor, 1999, The Journal of infectious diseases.

Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes.

J. Fahey, P. Nishanian, P. Nishanian, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.

D. Heitjan, J. Fahey, J. Giorgi, 1987, Journal of immunology.

A simple and rapid method for preparation of HIV-expressing targets for functional assays.

J. Giorgi, C. Uittenbogaart, P. Nishanian, 1988, Journal of immunological methods.

Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection

H. Morgenstern, T. Beaty, J. Margolick, 1993 .

Reference standards and quality performance considerations for measurements of cytokines and soluble markers of immune activation

J. Fahey, N. Aziz, P. Nishanian, 1998 .

Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.

R. Detels, W. Cumberland, J. Fahey, 1991, Clinical immunology and immunopathology.

Characterization of immune suppression by a synthetic HIV gp41 peptide.

Hong Wang, J. Fahey, P. Nishanian, 1995, Cellular immunology.